Looking to sell Solidus Labs stock or options?
Solidus Labs has developed a trade surveillance platform designed to enhance manipulation detection methods in the cryptocurrency market. The blockchain-native, machine learning-driven platform provides customized actionable alerts, efficient ticket management, and regulatory reporting by continually adapting to new manipulation schemes. This enables financial service providers to mitigate risk, boost transparency, and reduce costs when trading crypto assets.
Evolution Equity Partners, Avon Ventures, EXOR Seeds, Aleksandr Yampolskiy, Dawn Stump, Jeffrey Fagnan, Liberty City Ventures, Global Founders Capital, Matthew Homer, Daniel Gorfine, 645 Ventures, David Krell, FinTech Sandbox, Sam Kassoumeh, Troy Paredes, Christopher Giancarlo, Marc Epstein, Norman Sorensen, Naval Ravikant, Declaration Partners, Clara Chiu, Alex Acree, Brian Brooks, GSR, Hanaco Ventures.
Solidus Labs is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Solidus Labs stock. Depending on Solidus Labs’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Solidus Labs stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Solidus Labs stock in two ways. First, Solidus Labs employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Solidus Labs stock. Note that all transactions in Solidus Labs shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Solidus Labs stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Solidus Labs stock. Typically, shares of private companies like Solidus Labs are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On May 2022, Solidus Labs is reported to have closed an equity financing in which the investors valued the company at $289M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Solidus Labs shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Solidus Labs is not currently publicly traded, it does not have a ticker symbol.
Solidus Labs has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Solidus Labs is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Solidus Labs shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.